GRPI

Grupo International Inc. GRPI

GRPI
Grupo International Inc. BIMI
BIMI International Medical Inc. FSPM
FusionPharm, Inc. OMMH
Omnimmune Holdings, Inc. DMKPQ
DMK Pharmaceuticals Corporation CFRXQ
ContraFect Corporation IMVIF
IMV Inc. BGMD
BG Medicine, Inc. MILC
Millennium Sustainable Ventures Corp. ADLI
American Medical Technologies Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GRPI BIMI FSPM OMMH DMKPQ CFRXQ IMVIF BGMD MILC ADLI
6M 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % -90.00 % 9 900.00 % 0.00 % 0.00 %
YTD 0.00 % -52.38 % 0.00 % 0.00 % 0.71 % 0.00 % -90.00 % 0.00 % 0.00 % 0.00 %
1Y 0.00 % -88.24 % 0.00 % 0.00 % 907.14 % 0.00 % -90.00 % 0.00 % 0.00 % 0.00 %
3Y 9 900.00 % -99.95 % -50.00 % 0.00 % -99.99 % -100.00 % -100.00 % -75.00 % -99.95 % 0.00 %
5Y 0.00 % -100.00 % -95.00 % 0.00 % -100.00 % -100.00 % -100.00 % -99.71 % -99.96 % -99.09 %
10Y 0.00 % -100.00 % -99.50 % 0.00 % -100.00 % -100.00 % -100.00 % -99.98 % -99.98 % -94.12 %
From the beginning 0.00 % -100.00 % -100.00 % 0.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 %

Dividend